CareLink Express™ Mobile App
Our advancement into the smart technology arena means a mobile tablet can now be used to interrogate a patient’s cardiac device in a variety of healthcare settings (e.g., emergency rooms, operating room, procedural areas, hospital nursing floors). Using a Medtronic Patient Connector (Model 24967), an Apple®* tablet, and a free app; a device check can be done quickly — and sent securely to a device specialist for interpretation.
Medtronic cardiac device is interrogated in a healthcare setting using the Patient Connector and the CareLink Express mobile app on the tablet.
The app will confirm that the transmission was successful.
A Medtronic representative or device follow-up clinician (configurable by site) is notified of the transmission and reviews the data remotely on the CareLink Express website.
A telephone call is made by the reviewer to the clinician in the CareLink Express healthcare setting (where the patient’s device was interrogated) to discuss the technical findings.
The patient’s follow-up clinic receives transmission data for patients currently enrolled in the CareLink network.
A handheld telemetry wand called the patient connector
A Medtronic mobile application downloadable from the App Store®*
An Apple®** tablet
A carrying case that will house both the patient connector and the tablet
With CareLink Express Mobile, you can quickly determine the care pathway for your cardiac device patients. It can also help reduce the time your cardiac device patient spends in the acute care setting and can help hospitals avoid unnecessary (and costly) admissions for these patients.1-3
Why CareLink Express Mobile
Small R, Tang W, Wickemeyer W, et al. Managing Heart Failure Patients with Intra-Thoracic Impedance Monitoring: A Multi-Center US Evaluation (OFISSER). J Card Fail. August 2007;13(6); Supp 2;S113-S114.
Boriani G, Da Costa A, Ricci RP, et al. Monitoring Resynchronization devices and Cardiac patients (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res. August 21, 2013;15(8):e167.
Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. May 2012;33(9):1105-1111.
CareLink Express Mobile Product Design Files
Pre-CareLink Express pilot data collected in 5 Medtronic districts for 4 consecutive weeks. Results may vary.
**A list of supported tablets is available at www.medtronic.com/24967
Medtronic and the Medtronic logo are trademarks of Medtronic.™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Disclaimer: This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorization for use.